Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain.

Detrez JR, Maurin H, Van Kolen K, Willems R, Colombelli J, Lechat B, Roucourt B, Van Leuven F, Baatout S, Larsen P, Nuydens R, Timmermans JP, De Vos WH.

Neurobiol Dis. 2019 Jul;127:398-409. doi: 10.1016/j.nbd.2019.03.010. Epub 2019 Mar 14.

PMID:
30878534
2.

Anti-Tau Monoclonal Antibodies Derived from Soluble and Filamentous Tau Show Diverse Functional Properties in vitro and in vivo.

Vandermeeren M, Borgers M, Van Kolen K, Theunis C, Vasconcelos B, Bottelbergs A, Wintmolders C, Daneels G, Willems R, Dockx K, Delbroek L, Marreiro A, Ver Donck L, Sousa C, Nanjunda R, Lacy E, Van De Casteele T, Van Dam D, De Deyn PP, Kemp JA, Malia TJ, Mercken MH.

J Alzheimers Dis. 2018;65(1):265-281. doi: 10.3233/JAD-180404.

PMID:
30040731
3.

Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau.

van Ameijde J, Crespo R, Janson R, Juraszek J, Siregar B, Verveen H, Sprengers I, Nahar T, Hoozemans JJ, Steinbacher S, Willems R, Delbroek L, Borgers M, Dockx K, Van Kolen K, Mercken M, Pascual G, Koudstaal W, Apetri A.

Acta Neuropathol Commun. 2018 Jul 12;6(1):59. doi: 10.1186/s40478-018-0562-9.

4.

Giant dissecting aortic aneurysm in a chronic amphetamine user.

Van Kolen K, Spapen J, Vaerenberg M.

Acta Cardiol. 2019 Jun;74(3):263-264. doi: 10.1080/00015385.2018.1480454. Epub 2018 Jul 5. No abstract available.

PMID:
29975172
5.

A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities.

Apetri A, Crespo R, Juraszek J, Pascual G, Janson R, Zhu X, Zhang H, Keogh E, Holland T, Wadia J, Verveen H, Siregar B, Mrosek M, Taggenbrock R, Ameijde J, Inganäs H, van Winsen M, Koldijk MH, Zuijdgeest D, Borgers M, Dockx K, Stoop EJM, Yu W, Brinkman-van der Linden EC, Ummenthum K, van Kolen K, Mercken M, Steinbacher S, de Marco D, Hoozemans JJ, Wilson IA, Koudstaal W, Goudsmit J.

Acta Neuropathol Commun. 2018 May 31;6(1):43. doi: 10.1186/s40478-018-0543-z.

6.

Emergence of early alterations in network oscillations and functional connectivity in a tau seeding mouse model of Alzheimer's disease pathology.

Ahnaou A, Moechars D, Raeymaekers L, Biermans R, Manyakov NV, Bottelbergs A, Wintmolders C, Van Kolen K, Van De Casteele T, Kemp JA, Drinkenburg WH.

Sci Rep. 2017 Oct 27;7(1):14189. doi: 10.1038/s41598-017-13839-6.

7.

Unusual timing of a common complication after pulmonary vein isolation.

Van Kolen K, Ströker E, De Greef Y.

Neth Heart J. 2017 Nov;25(11):645-646. doi: 10.1007/s12471-017-1027-7. Epub 2017 Aug 1. No abstract available.

8.

Giant left circumflex coronary artery aneurysm with fistula to the right atrium.

Spapen J, Van Kolen K, Gigase A, Vermeersch P.

Acta Cardiol. 2018 Apr;73(2):200-201. doi: 10.1080/00015385.2017.1351257. Epub 2017 Jul 26.

PMID:
28745134
9.

Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivo.

Vasconcelos B, Stancu IC, Buist A, Bird M, Wang P, Vanoosthuyse A, Van Kolen K, Verheyen A, Kienlen-Campard P, Octave JN, Baatsen P, Moechars D, Dewachter I.

Acta Neuropathol. 2016 Apr;131(4):549-69. doi: 10.1007/s00401-015-1525-x. Epub 2016 Jan 6.

10.

Fever after acute myocardial infarction: Dressler's syndrome demonstrated on cardiac MRI.

Van Kolen K, Jogani S, Belmans A, Schurmans J.

Int J Cardiol. 2015 Mar 15;183:209-10. doi: 10.1016/j.ijcard.2014.12.086. Epub 2015 Jan 7. No abstract available.

PMID:
25675902
11.

LRRK2 functions in synaptic vesicle endocytosis through a kinase-dependent mechanism.

Arranz AM, Delbroek L, Van Kolen K, Guimarães MR, Mandemakers W, Daneels G, Matta S, Calafate S, Shaban H, Baatsen P, De Bock PJ, Gevaert K, Vanden Berghe P, Verstreken P, De Strooper B, Moechars D.

J Cell Sci. 2015 Feb 1;128(3):541–52.

12.

Transient left ventricular apical ballooning syndrome in a patient with allopurinol induced skin rash: a case report.

Bernards J, Van Kolen K, Govaerts E, Somville FJ, von Stritzky M.

Int J Cardiol. 2014 Dec 15;177(2):e53-5. doi: 10.1016/j.ijcard.2014.09.130. Epub 2014 Oct 11. No abstract available.

PMID:
25305677
13.

Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice.

Peeraer E, Bottelbergs A, Van Kolen K, Stancu IC, Vasconcelos B, Mahieu M, Duytschaever H, Ver Donck L, Torremans A, Sluydts E, Van Acker N, Kemp JA, Mercken M, Brunden KR, Trojanowski JQ, Dewachter I, Lee VM, Moechars D.

Neurobiol Dis. 2015 Jan;73:83-95. doi: 10.1016/j.nbd.2014.08.032. Epub 2014 Sep 16.

14.

Intrathymic parathyroid adenoma presenting with seizures.

Pierrache L, Van Kolen K, Heyman S, Van Schil P.

Acta Chir Belg. 2013 Jan-Feb;113(1):51-3. Review.

PMID:
23550471
15.

Investigation of signalling cascades induced by neurotrophic synaptolepis factor K7 reveals a critical role for novel PKCε.

Van Kolen K, Bruinzeel W, He W, De Kimpe N, Van Puyvelde L, Cik M, Pullan S.

Eur J Pharmacol. 2013 Feb 15;701(1-3):73-81. doi: 10.1016/j.ejphar.2013.01.004. Epub 2013 Jan 20.

PMID:
23340224
16.

Development of an enzyme-linked immunosorbent assay for detection of cellular and in vivo LRRK2 S935 phosphorylation.

Delbroek L, Van Kolen K, Steegmans L, da Cunha R, Mandemakers W, Daneels G, De Bock PJ, Zhang J, Gevaert K, De Strooper B, Alessi DR, Verstreken P, Moechars DW.

J Pharm Biomed Anal. 2013 Mar 25;76:49-58. doi: 10.1016/j.jpba.2012.12.002. Epub 2012 Dec 16.

17.

LRRK2 controls an EndoA phosphorylation cycle in synaptic endocytosis.

Matta S, Van Kolen K, da Cunha R, van den Bogaart G, Mandemakers W, Miskiewicz K, De Bock PJ, Morais VA, Vilain S, Haddad D, Delbroek L, Swerts J, Chávez-Gutiérrez L, Esposito G, Daneels G, Karran E, Holt M, Gevaert K, Moechars DW, De Strooper B, Verstreken P.

Neuron. 2012 Sep 20;75(6):1008-21. doi: 10.1016/j.neuron.2012.08.022.

18.

Debulking of stage IVA thymoma.

Cogen A, Van Kolen K, Pierrache L, Hertoghs MG, Hendriks JM, Lauwers PR, Luijks AC, Mercelis RJ, Van Schil PE.

Multimed Man Cardiothorac Surg. 2012 Jan 1;2012:mms020. doi: 10.1093/mmcts/mms020.

19.

Prognostic factors and genetic markers in thymoma.

Van Kolen K, Pierrache L, Heyman S, Pauwels P, Van Schil P.

Thorac Cancer. 2010 Nov;1(4):133-140. doi: 10.1111/j.1759-7714.2010.00028.x. Review.

PMID:
27755821
20.

Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2.

Van Kolen K, Dautzenberg FM, Verstraeten K, Royaux I, De Hoogt R, Gutknecht E, Peeters PJ.

Neuropharmacology. 2010 Jan;58(1):135-44. doi: 10.1016/j.neuropharm.2009.06.022. Epub 2009 Jun 30. Erratum in: Neuropharmacology. 2010 Feb;58(2):559. Dautzenberg, Frank M [added].

PMID:
19573542
21.

Molecular mechanisms of corticotropin-releasing factor receptor-induced calcium signaling.

Gutknecht E, Van der Linden I, Van Kolen K, Verhoeven KF, Vauquelin G, Dautzenberg FM.

Mol Pharmacol. 2009 Mar;75(3):648-57. doi: 10.1124/mol.108.050427. Epub 2008 Dec 19.

PMID:
19098121
22.

Integration of P2Y receptor-activated signal transduction pathways in G protein-dependent signalling networks.

Van Kolen K, Slegers H.

Purinergic Signal. 2006 Sep;2(3):451-69. doi: 10.1007/s11302-006-9008-0. Epub 2006 Jun 7.

23.

Obestatin induction of early-response gene expression in gastrointestinal and adipose tissues and the mediatory role of G protein-coupled receptor, GPR39.

Zhang JV, Jahr H, Luo CW, Klein C, Van Kolen K, Ver Donck L, De A, Baart E, Li J, Moechars D, Hsueh AJ.

Mol Endocrinol. 2008 Jun;22(6):1464-75. doi: 10.1210/me.2007-0569. Epub 2008 Mar 12.

24.

Nociceptive and behavioural sensitisation by protein kinase Cepsilon signalling in the CNS.

Van Kolen K, Pullan S, Neefs JM, Dautzenberg FM.

J Neurochem. 2008 Jan;104(1):1-13. Epub 2007 Oct 30. Review.

25.
26.

P2Y12 receptor signalling towards PKB proceeds through IGF-I receptor cross-talk and requires activation of Src, Pyk2 and Rap1.

Van Kolen K, Gilany K, Moens L, Esmans EL, Slegers H.

Cell Signal. 2006 Aug;18(8):1169-81. Epub 2005 Oct 19.

PMID:
16236484
28.

Reactive blue 2 inhibition of cyclic AMP-dependent differentiation of rat C6 glioma cells by purinergic receptor-independent inactivation of phosphatidylinositol 3-kinase.

Claes P, Van Kolen K, Roymans D, Blero D, Vissenberg K, Erneux C, Verbelen JP, Esmans EL, Slegers H.

Biochem Pharmacol. 2004 Apr 15;67(8):1489-98.

PMID:
15041466
29.

Agonists of the P2Y(AC)-receptor activate MAP kinase by a ras-independent pathway in rat C6 glioma.

Grobben B, Claes P, Van Kolen K, Roymans D, Fransen P, Sys SU, Slegers H.

J Neurochem. 2001 Sep;78(6):1325-38.

30.

Supplemental Content

Loading ...
Support Center